Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, Masood Shammas, Amer Mahmood, Sulman Basit, Sarah AlMukhaylid, Zafar Iqbal. CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML. J Popl Ther Clin Pharmacol [Internet]. 2022 Feb. 23 [cited 2024 Jul. 16];29(02):311-20. Available from: https://jptcp.com/index.php/jptcp/article/view/4161